EUVIMEDScopri EUVIMED
VergleichsstudieRandomisierte kontrollierte Studie

Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo

Manal Fawzy iD, Sahar Al-Mokadem, Mabrokah Alshereef, Basma Elkholy

Photodermatology, Photoimmunology & Photomedicine · 2024-01 · 40 (1)

DOI: 10.1111/phpp.12929 ↗

At a glance

Vergleichsstudie in Photodermatology, Photoimmunology & Photomedicine, published online on 2023-11-20. Written by Manal Fawzy and 3 co-authors. Institution: Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Major MEDLINE topics: Platelet-Rich Plasma, Ultraviolet Therapy, Vitiligo. Cited 8 times so far (Crossref); 29 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Narrowband ultraviolet B (NB‐UVB) phototherapy is the cornerstone of vitiligo treatment. Its combination with other treatments usually yields a better response. Latanoprost, a prostaglandin F2α analog, and autologous platelet‐rich plasma (PRP) have been reported to be effective for vitiligo.

Aim

To evaluate the efficacy of NB‐UVB combined with intralesional latanoprost or PRP for stable nonsegmental vitiligo (NSV).

Methods

Sixty patients with stable NSV were recruited and randomly allocated to two equal groups. NB‐UVB phototherapy was administered twice a week for all patients. Additionally, group A received intralesional latanoprost injections once weekly, while group B received intralesional autologous PRP injections every 2 weeks.

Results

At 24 weeks, excellent repigmentation response was observed in 26.7% and 13.3% of patients in the latanoprost/NB‐UVB and PRP/NB‐UVB groups, respectively, with no significant difference in degrees of repigmentation between the two groups. However, the Vitiligo Extent Score for a Target Area (VESTA) score was significantly higher in the latanoprost/NB‐UVB group ( p = .032). Moreover, lesions located on nonacral skin responded significantly better than those on acral skin. Only erythema was significantly higher in the PRP/NB‐UVB group, while the recurrence of depigmentation was significantly higher in the latanoprost/NB‐UVB group.

Conclusions

Both latanoprost and PRP have the potential to be effective add‐on therapies to NB‐UVB phototherapy for stable NSV, with latanoprost resulting in a greater repigmentation response and PRP producing a more stable response.

Subjects

MeSH terms (MEDLINE)

Platelet-Rich PlasmaUltraviolet TherapyVitiligoHumansCombined Modality TherapyInjections, IntralesionalLatanoprostTreatment OutcomeProspective Studies

Author keywords

latanoprostnarrowband ultraviolet Bplatelet-rich plasmatreatmentvitiligo

Substances

Latanoprost

Authors and institutions

  • Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

ORCID profiles: Manal Fawzy

Cite

APA

Fawzy, M., Al-Mokadem, S., Alshereef, M., & Elkholy, B. (2024). Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo. Photodermatology, Photoimmunology & Photomedicine, 40(1). https://doi.org/10.1111/phpp.12929

Vancouver

Fawzy M, Al-Mokadem S, Alshereef M, Elkholy B. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo. Photodermatology, Photoimmunology & Photomedicine. 2024;40(1). doi:10.1111/phpp.12929

BibTeX
@article{Fawzy2024,
  author = {Fawzy, Manal and Al-Mokadem, Sahar and Alshereef, Mabrokah and Elkholy, Basma},
  title = {Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet‐rich plasma for stable nonsegmental vitiligo},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2024},
  volume = {40},
  number = {1},
  doi = {10.1111/phpp.12929}
}
Start for free →